The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Androgenic Alopecia
- Sponsor
- Pusan National University Hospital
- Enrollment
- 38
- Primary Endpoint
- change of total hair counts by phototrichogram
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks.
Detailed Description
This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks. Hair count and thickness will be primary outcomes.
Investigators
Sang Yeoup Lee
professor
Pusan National University Hospital
Eligibility Criteria
Inclusion Criteria
- •androgenic alopecia basic and specific(BASP) classification: M2, C2, U1, V1, or F1 or higher
Exclusion Criteria
- •patient of scalp disease
Outcomes
Primary Outcomes
change of total hair counts by phototrichogram
Time Frame: 16 weeks